» Articles » PMID: 17621875

The Hedgehog Pathway As a Drug Target in Cancer Therapy

Overview
Date 2007 Jul 12
PMID 17621875
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

As with other developmentally important signaling pathways such as Wnt, TGF or Notch signaling, the Hedgehog (Hh) pathway has been shown to play an important role in the formation of several tumor types, including pancreas, prostate, skin and brain cancer. As the prognosis for some of these cancers is still poor, the Hh pathway may represent a novel drug target with high therapeutic potential. This review describes the mechanisms of signal transduction of the Hh pathway and the alterations that lead to tumor formation, highlighting the several drug development programs that are aimed at correcting these alterations.

Citing Articles

Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma.

Wang L, Jin J, Zhou Y, Tian Z, Jablons D, He B Oncotarget. 2018; 9(1):853-865.

PMID: 29416661 PMC: 5787518. DOI: 10.18632/oncotarget.22856.


Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells.

Oladapo H, Tarpley M, Sauer S, Addo K, Ingram S, Strepay D Cancer Lett. 2017; 411:136-149.

PMID: 28965853 PMC: 5720365. DOI: 10.1016/j.canlet.2017.09.033.


Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer.

Subramaniam D, Kaushik G, Dandawate P, Anant S Curr Med Chem. 2017; 25(22):2585-2594.

PMID: 28137215 PMC: 5630517. DOI: 10.2174/0929867324666170127095832.


GLI1 inhibitor GANT61 exhibits antitumor efficacy in T-cell lymphoma cells through down-regulation of p-STAT3 and SOCS3.

Geng L, Lu K, Li P, Li X, Zhou X, Li Y Oncotarget. 2016; 8(30):48701-48710.

PMID: 27275540 PMC: 5564718. DOI: 10.18632/oncotarget.9792.


Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup.

Miele E, Mastronuzzi A, Po A, Carai A, Alfano V, Serra A Biomark Res. 2015; 3:13.

PMID: 26064523 PMC: 4462002. DOI: 10.1186/s40364-015-0038-z.